Tonix Pharmaceuticals Holding Corp (TNXP) Event July 29, 2022, 21:01 UTC (99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Reports Q3 2022 Financial Results Full text
Register to leave comments News bot Oct. 2, 2025, 4:46 p.m. 📋 TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) - Financial Results Filing Date: 2022-07-29 Accepted: 2022-07-29 17:01:41 Event Type: Financial Results Event Details: Tonix Pharmaceuticals Holding Corp (TNXP) Reports Q3 2022 Financial Results Tonix Pharmaceuticals Holding Corp (TNXP) announced its financial results for the period ending Q3 2022. Key Financial Highlights: Revenue: Not disclosed Net Income: Not disclosed EPS: Not disclosed Cash and equivalents: $23 📊 Key Financial Metrics: Metric Value Net Loss $23 Cash $23 💼 Business Developments: No business developments data available. Structured Data: Company Name: Tonix Pharmaceuticals Holding CorpCIK: 0001430306Ticker Symbol: TNXPPeriod End Date: 2022-07-29Document Type: 8-K
📋 TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) - Financial Results
Filing Date: 2022-07-29
Accepted: 2022-07-29 17:01:41
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
No business developments data available.
Structured Data: